IL33 and Hepatic fibrosis: Our overall observation of a lack of association between plasma IL-33 and schistosomiasis-driven live disease progression is contrasting with previous reports that have suggested the increase of IL-33 with hepatic fibrosis in general (29, 74) and hepatic schistosomiasis-driven liver fibrosis in particular (56).